Management of restenosis in drug-eluting stents: Still a challenge

Journal of Invasive Cardiology

Volumn 22, Issue 5, 2010, Pages 220-221

  Gupta, Mohit ^a   Kadakia, Jigar ^a   Budoff, Matthew J ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ANTICOAGULANT THERAPY; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG MECHANISM; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NOTE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; SEPTIC SHOCK; STENT THROMBOSIS; RISK FACTOR; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; RISK FACTORS;

EID: 77955868564     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Lemos PA, Saia F, Hofma SH, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708.
2. Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-1930.
3. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
4. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009;119:3198-3206.
5. Lee SS, Price MJ, Wong GB, et al. Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure. Am J Cardiol 2006;98:1345-1348.
6. Mishkel GJ, Moore AL, Markwell S, et al. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007;49:181-184.
7. Levisay JP, Price MJ, Shaba W, et al. Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol 2010;22:216-219.
8. Mehilli J, Byrne RA, Tiroch K, et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010, Mar 5. Epub ahead of print.
9. Cosgrave J, Melzi G, Corbett S, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. Am Heart J 2007;153:354-359.
10. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124.